Watson Pharmaceuticals Inc.

Recent Events

News & Analysis

healthcare and watson pharmaceuticals inc. - All News and Analysis

• Watson Pharmaceutical Financial Gauge Analysis for the September 2009 Quarter

  Seeking Alpha - 2009-11-25

  Neil Carvin submits: In a previous article, we examined Watson Pharmaceuticals' WPI Income Statement for the third quarter of 2009 and compared the entries on each line to our "look-ahead" estimates. Earnings in this period, which ended 30 September 2009, fell from $0.60 to $0.54 per share. ...

  Tags: Healthcare, Neil Carvin, Watson Pharmaceuticals Inc.

• Watson Pharmaceuticals: Income Statement Analysis for the September 2009 Quarter

  Seeking Alpha - 2009-11-08

  Neil Carvin submits: Watson Pharmaceuticals, Inc. WPI earned $0.54 per share in the third quarter of 2009, down from $0.60 in the same quarter of last year. [Note: our per-share numbers are slightly different than the official results because we don't adjust for interest expenses on convertible contingent...

  Tags: Healthcare, Neil Carvin, Watson Pharmaceuticals Inc.

• Watson Pharma Look-Ahead to September 2009 Quarterly Results

  Seeking Alpha - 2009-09-23

  Neil Carvin submits: The GCFR Overall Gauge of Watson Pharmaceuticals, Inc. (NYSE: WPI) slipped from 43 to 39 of the 100 possible points in the second quarter of 2009. Our income statement and financial gauge analyses explained in some detail how the score was attained....

  Tags: Healthcare, Neil Carvin, Watson Pharmaceuticals Inc.

• Watson Pharma Financial Gauge Analysis for June 2009 Quarter

  Seeking Alpha - 2009-08-04

  Neil Carvin submits: In an earlier post, we examined Watson Pharmaceuticals' (NYSE: WPI) Income Statement for the June quarter and compared the figures to our "look-ahead" estimates. Second-quarter earnings fell from $0.51 to $0.46 per share, primarily because of the costs to launch the RAPAFLO and Gelnique...

  Tags: Healthcare, Neil Carvin, Watson Pharmaceuticals Inc.

• Watson Pharma Income Statement Analysis for June 2009 Quarter

  Seeking Alpha - 2009-07-30

  Neil Carvin submits: Watson Pharmaceuticals, Inc. (NYSE: WPI) earned $0.46 per share during the three months that ended on 30 June 2009, down from $0.51 in last year's second quarter. This post examines the Income Statement for the quarter and compares it to our "look-ahead" estimates....

  Tags: Healthcare, Neil Carvin, Watson Pharmaceuticals Inc.

• Watson Pharmaceuticals, Inc. Q2 2009 Earnings Call Transcript

  Seeking Alpha - 2009-07-29

  Watson Pharmaceuticals, Inc. WPI Q2 2009 Earnings Call Transcript July 29, 2009 8:30 am ET

  Tags: Healthcare, Watson Pharmaceuticals Inc.

• Watson Pharmaceuticals: A Potent Drug Combination

  Seeking Alpha - 2009-01-06

  Paul Price submits: Watson WPI develops, manufactures and markets both generic and branded drugs. It also holds a 50% interest in Somerset Pharmaceuticals a joint venture with Mylan Labs MYL. It previously had acquired Andrx Group in November 2006, bringing its stable of marketed products to...

  Tags: Healthcare, Paul Price, Mylan Inc., Watson Pharmaceuticals Inc.

• Healthcare Stocks to Watch: HSXI, HEPH, OPXA, WPI.

  - 2008-03-12

  M2 PRESSWIRE-12 March 2008-Financialbusinessnews.us: Healthcare Stocks to Watch: HSXI, HEPH, OPXA, WPIC1994-2008 M2 COMMUNICATIONS LTD RDATE:12032008 Boston, MA -- HealthSonix, Inc. (OTC: HSXI); Hollis-Eden Pharmaceuticals, Inc. (NASDAQ: HEPH); Opexa Therapeutics, Inc. (NASDAQ: OPXA); Watson Pharmaceuticals, Inc. (NYSE: WPI) ...

  Tags: Benefits, Company, efficacy, HEALTHCARE, Nasdaq Stock Market Inc., Opexa Therapeutics Inc., patient, SOFTWARE, therapy, Watson Pharmaceuticals Inc.